A new antiparasitic target representing a new structure in the range of active molecules directed against apicomplexan (vectors of malaria and toxoplasmosis) has been highlighted by researchers of the Plant Cell & Physiology Laboratory of our institute and of the high throughput screening platform of our laboratory.